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Abstract
Objective:  To determine the population incidence of juvenile rheumatoid arthritis (JRA) in
Quebec.
Methods: We obtained data from Quebec's physician claims database. Incident cases were defined
as having a visit for JRA in 2000, no visit in the previous 3 years, a confirmed diagnosis by an arthritis
specialist, or having ≥ 2 visits to any physician for JRA, ≥ 2 months apart but within 2 years.
Results: Cumulative incidence of JRA was 17.8/100,000. Mean age at diagnosis was 9.8 ± 4.6 years,
68% were female and more persons were diagnosed in winter. Subjects had a median of 10 medical
visits over the first year.
Conclusion:  Our population based incidence estimate was similar to others. Children and
adolescents with JRA are heavy users of medical care. Additional study of environmental or climate-
related triggers may be warranted.
Background
Juvenile idiopathic arthritis (JIA) is a group of inflamma-
tory arthropathies that includes three main groups: juve-
nile rheumatoid arthritis (JRA), juvenile
spondyloarthropathies (or enthesitis-related arthritides)
and juvenile psoriatic arthritis [1]. The etiology is
unknown and the pathophysiology is poorly understood.
Due to the effects of chronic inflammation on joints,
affected children often suffer permanent disability,
impaired functional status, and poor quality of life in
their adult lives [2]. However, recent advances in treat-
ment appear promising and early drug therapy combined
with rehabilitation can optimize outcomes [3].
Epidemiologic studies have noted a relatively wide inci-
dence of juvenile arthritis ranging between approximately
10 and 23 per 100,000 persons, with a known female pre-
dominance [4-7]. Variations in estimates may be due to
differences in diagnostic criteria, case ascertainment, or to
regional and time differences [8,9]. Most of the incidence
studies to date have relied only on physician reporting.
We sought to determine the incidence of JRA in the prov-
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ince of Quebec, Canada using a physician reimbursement
database that covers the entire population. We report inci-
dence for JRA (as opposed to JIA) since the database con-
tains a well-defined code for this diagnosis.
Methods
We obtained data from a physician claims administrative
database covering all residents of the province of Québec
(the Régie de l'assurance maladie du Québec: RAMQ),
after receiving permission from the Commission d'accès à
l'information du Québec (Quebec Access to Information
Commission). Our study population consisted of all chil-
dren, 16 years and under, who had a visit to a physician
for JRA (International Classification of Diseases-9 code
714) in the year 2000. Data were available for these chil-
dren and adolescents for the period between January 1997
and June 2003.
Among the 842 children and adolescents with at least one
physician visit coded for JRA in the year 2000 (which we
considered as suspected cases of JRA), we established that
523 had had no prior physician visits for JRA in the pre-
ceding 3 years. For a more specific case-definition of inci-
dent JRA among these 523 subjects with suspected JRA, we
included only incident cases that had either been diag-
nosed by a pediatric arthritis specialist, or who had ≥ 2 vis-
its for JRA at least two months apart but within a two year
span [10]. We included as pediatric arthritis specialists all
rheumatologists, internists or pediatric immunologists
who had provided care for JRA patients in a pediatric hos-
pital, and all pediatricians who over the study period had
recorded over 50 JRA patient visits.
We report the cumulative incidence of juvenile arthritis
for the year 2000. In addition, we describe incidence by
sex, season, and socio-economic status. Socioeconomic
status was based on a validated indicator that utilizes
postal code to estimate neighborhood socioeconomic sta-
tus and provides an ecological index of material and social
deprivation [11]. We dichotomized socioeconomic status
at the top two quintiles versus the lower three. We also
describe medical service use for the incident JRA cases.
Results
We identified 267 new cases of JRA in 2000, in the prov-
ince of Quebec - 203 were diagnosed by an arthritis spe-
cialist and 64 by a pediatrician, family physician or
another specialist (Figure 1). Based on census data, there
Definition of incident JRA cases in Quebec Figure 1
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were approximately 1.5 million Quebec residents aged ≤
16 in 2001, so we estimate the incidence of JRA in 2000 as
17.8 cases per 100,000 (95% confidence interval: 16.05/
100,000, 19.55/100,000). The mean age at diagnosis was
9.8 years (standard deviation 4.56, median 10.0).
Descriptive statistics are recorded in Table 1. There was a
trend (P < 0.01) suggesting more incident cases in the
winter season (December 21-March 20)[12].
In the first year post diagnosis, the median number of
total doctor visits was 10 (inter-quartile range (IQR) 6-
17). Medical visits are described in Table 2.
Discussion
Our study produced the first population-based cumula-
tive incidence for JRA in Quebec. This was estimated at
17.8 cases per 100,000 Quebec residents aged ≤ 16, a fig-
ure within the range of other incidence studies of juvenile
arthritis to date. We noted a clear female preponderance
of JIA which is in keeping with known demograph-
ics,[5,13]. and mean age at diagnosis was also consistent
[5,7].
Our results are similar to the JRA incidence rate of 19.5/
100,000 in Finland [5], JIA incidence rate of 21.7/100,000
in Estonia,[7] and 15/100,000 in the Nordic countries [6].
Although we have not validated our algorithm with
patient clinical data, the coherence of these rates with
other studies that use clinical data suggests that adminis-
trative data may be useful to study the epidemiology of
JRA. Further, our study covered the entire population of
the province of Québec including those living in rural and
outlying regions.
According to our data, there was a trend towards first diag-
nosis during the winter months. One study from Israel has
suggested subsets of JRA may be more common in winter
and spring, [14] although this was not seen in a large
Canadian study [15]. Unfortunately, we could not distin-
guish between specific JRA sub-types from our administra-
tive data.
Children and adolescents who are newly diagnosed with
JRA appear to be heavy users of medical care, on average
experiencing 17.4 physician visits in the first year post-
diagnosis. In comparison, 2004 National Ambulatory
Medical Care Survey data suggested an average of 2.4 phy-
sician visits per year among children aged ≤ 15 years [16].
Brunner et al., in a sample of prevalent JRA patients,
reported similar figures to ours in terms of average rheu-
matology visits (between 4.4 and 5.8 visits per year) and
ophthalmology visits(between1.6 to 2.0) [17]. A British
study indicated that children with asthma had, on aver-
age, 3.4 to 4.4 annual visits for asthma to out-patient gen-
eral practice [18]. Although these figures are comparable
to ours with respect to visits for JRA to an arthritis special-
ist, total medical visits and pediatric or family physician
visits are higher in our cohort, possibly indicative of
higher medical care use by children with JRA.
Since our study relies on data from an administrative data-
base, there are important potential limitations. There is
no indication of severity or type of arthritis- factors which
influence medical visits and costs [19]. Nevertheless, our
study does cover the entire population of the province of
Quebec and provides estimates of JRA incidence and med-
ical care use on a population level. Another limitation is
that the incidence may have been over-estimated if chil-
dren and adolescents with previously diagnosed disease
moved to Quebec and were included as incident cases in
our study.
In conclusion, our population-based study of children
and adolescents in Quebec estimated 17.8 incident JRA
cases per 100,000 which is similar to physician-reported
studies. We confirmed that these individuals are heavy
users of medical care, which emphasizes the impact of
arthritis in the young. As well, the suggestion of seasonal
Table 1: Description of Incident Cases of JRA
N = 267 n %
Girls 181 67.8
High socioeconomic status 115 43.9
Season of diagnosis
Winter (December 21-March 20) 79 29.6
Spring (March 21-June 20) 60 22.5
Summer (June21-September 20) 63 23.6
Fall (September21-December 20) 65 24.3
Table 2: Medical visits for incident cases of JRA (n = 267), over 
the first 12 months following initial diagnosis
12 months post diagnosis
Mean (SD) Median (IQR)
All medical visits 17.4 (28.4) 10.0 (6.0-17.0)
Arthritis specialist 4.3 (5.6) 3.0 (1.0-5.0)
Pediatrician or Family Physician 6.3 (9.6) 3.0 (2.0-7.0)
Ophthalmologist 1.8 (1.7) 1.0 (0.0-2.0)
Radiologist 0.8 (1.9) 0.0 (0.0-1.0)
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trends may mean that additional study of environmental
triggers in JRA is warranted.
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